Healio5h
FDA approves Evrysdi tablets for spinal muscular atrophy
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
PMLiVE9h
Roche’s Evrysdi tablet formulation granted FDA approval for spinal muscular atrophy
Roche has announced that a tablet formulation of its spinal muscular atrophy (SMA) treatment Evrysdi (risdiplam) has been ...
BioSpace1d
Roche’s Evrysdi Becomes First Pill Cleared for Spinal Muscular Atrophy
The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...
How a tiny spinal implant could help those with muscle-wasting disease
How a tiny spinal implant could help those with muscle-wasting disease - Three people with a muscle-destroying disease got ...
The Associated Press on MSN9d
A spine-zapping implant helped 3 people with a muscle-wasting disease walk better
Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their ...
FDA Approves New Tablet Form of Evrysdi for Treatment of Spinal Muscular Atrophy
The Muscular Dystrophy Association celebrates this new more accessible treatment option for people living with SMA. MDA - New ...
Reawakening Dormant Nerve Cells: Groundbreaking Neurotechnology Restores Motor Function in SMA
A new electrical stimulation therapy for spinal muscle atrophy (SMA) has shown promise in reactivating motor neurons and ...
Medical Xpress on MSN9d
Spinal cord stimulation restores neural function, targets key feature of progressive neurodegenerative disease
Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle ...
Neurology Advisor4d
Children With SMA Type 1 See Increase in Life Expectancy With Treatment
Infants with SMA type 1 born since 2016 experience better functional outcomes and life expectancy with disease-modifying treatments.
The American Journal of Managed Care2d
Risdiplam Tablet for Spinal Muscular Atrophy Receives FDA Approval
The 5 mg risdiplam tablet provides the same efficacy and safety for spinal muscular atrophy as the currently available oral ...
Pharm Exec1d
FDA Approves Roche’s Evrysdi for Spinal Muscular Atrophy
Evrysdi is a non-invasive, disease-modifying option that can be swallowed whole or dispersed in water for patients with ...
manilatimes2d
FDA approves Roche's Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and safety as the currently ...